Back to top

Can-Fite Completes Key Phase 3 Psoriasis Enrolment Milestone for Piclidenoson

The latest announcement is out from Can-Fite BioPharma ( ($CANF) ). On July 6, 2026, Can-Fite BioPharma announced it has completed enrolment of the...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Can-Fite Biopharma Ltd (CANF)